AABB put out a call for questions for the "Ask the FDA and CMS/CLIA" session at the 2025 AABB Annual Meeting.
The Q&A “provides an opportunity for members to submit questions to FDA and CMS/CLIA representatives regarding the agencies’ current thinking on policies, regulations, guidance documents and inspection programs relevant to the oversight of blood and biotherapies.”
AABB recommends “when submitting questions, individuals should identify the regulation or recommendation of interest, the specific issue or concern, and any background information, as well as suggestions or proposed solutions to best illustrate their perspective.”
Questions are due by August 8.
